🔥 JUST IN: The board of Nasdaq-listed BioNexus Gene Lab has approved Ethereum as its primary treasury asset. The company also released an Ethereum Strategy Whitepaper, highlighting the asset’s institutional reliability, staking rewards, financial dominance, and scalability.